Watkins-Conti Products, Inc. has announced positive clinical trial results for Yōni.Fit®, an FDA-cleared bladder support device designed to help women manage stress urinary incontinence (SUI). The peer-reviewed study, published in Urogynecology, demonstrated the device’s effectiveness and safety, offering a non-surgical solution for millions of women affected by SUI.
The randomized, controlled trial involved women with SUI and was conducted by researchers at Stanford, NYU Langone, and Jefferson Health. Results showed that Yōni.Fit® significantly reduced urine leakage compared to a control device, with no serious adverse events reported. The device, made from 100% medical-grade silicone, is self-administered and can be worn for up to 12 hours.
Dr. Karolynn T. Echols, an investigator in the study, highlighted Yōni.Fit®’s superior performance, noting its potential to improve the quality of life for women with SUI. Dr. Darren Walter Goff, an OB-GYN, emphasized its convenience for postpartum patients who may not be ready for surgery.
“With just one office or telehealth visit, I can prescribe Yōni.Fit® and bring immediate relief to these patients,” said Dr. Goff.
Yōni.Fit® represents a significant advancement in non-surgical SUI management, with plans for nationwide distribution. Its ease of use and clinical efficacy make it a promising option for women seeking relief from this common condition.
Add comment